JESSICA LOGEL: Open Payments
NPI 1417615667 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,275 in 68 payments from 8 companies in 2025. Trend: 2023 $829 · 2024 $1,740 · 2025 $3,275
Food & beverage: $3,082Education: $193
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $1,288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $1,067 |
| Janssen Pharmaceuticals, Inc | 4 | $256 |
| Otsuka America Pharmaceutical, Inc. | 3 | $250 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| Alkermes, Inc. | 1 | $104 |
| Neurocrine BioSciences, Inc. | 3 | $79 |
Products named: CAPLYTA, UZEDY, AUSTEDO XR, INVEGA SUSTENNA, TEZSPIRE, REXULTI, ABILIFY MAINTENA, COBENFY.
Industry payments across CT — which companies pay providers there.
